Darin Lippoldt Neurocrine Biosciences Inc (NBIX) insider trading activity

Darin Lippoldt is Chief Legal Officer of NEUROCRINE BIOSCIENCES INC. Currently has a direct ownership of 39,740 shares of NBIX, which is worth approximately $4.78 Million. The most recent transaction as insider was on Aug 01, 2024, when has been sold 2,996 shares (Common Stock) at a price of $154.01 per share, resulting in proceeds of $461,413. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 39.7K

0% 3M change

15.09% 12M change

Total Value Held $4.78 Million

Darin Lippoldt Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 01 2024	SELL Open market or private sale	$461,413 $154.01 p/Share	2,996 Reduced 7.01%	39,740 Common Stock
Aug 01 2024	BUY Exercise of conversion of derivative security	$236,743 $79.02 p/Share	2,996 Added 6.55%	42,736 Common Stock
Jul 16 2024	SELL Open market or private sale	$1,050,600 $150.0 p/Share	7,004 Reduced 14.98%	39,740 Common Stock
Jul 16 2024	BUY Exercise of conversion of derivative security	$553,456 $79.02 p/Share	7,004 Added 13.03%	46,744 Common Stock
Feb 13 2024	SELL Open market or private sale	$146,023 $132.99 p/Share	1,098 Reduced 2.69%	39,740 Common Stock
Feb 08 2024	SELL Open market or private sale	$122,292 $134.24 p/Share	911 Reduced 2.3%	38,755 Common Stock
Feb 06 2024	SELL Open market or private sale	$147,998 $142.17 p/Share	1,041 Reduced 2.67%	37,939 Common Stock
Jan 31 2024	SELL Open market or private sale	$175,812 $140.65 p/Share	1,250 Reduced 3.27%	37,005 Common Stock
Jan 22 2024	SELL Open market or private sale	$1,398,600 $139.86 p/Share	10,000 Reduced 21.8%	35,882 Common Stock
Jan 22 2024	BUY Exercise of conversion of derivative security	$790,200 $79.02 p/Share	10,000 Added 17.89%	45,882 Common Stock
Dec 06 2023	SELL Open market or private sale	$2,496,683 $119.86 p/Share	20,830 Reduced 36.73%	35,882 Common Stock
Dec 06 2023	BUY Exercise of conversion of derivative security	$900,689 $43.24 p/Share	20,830 Added 26.86%	56,712 Common Stock
Nov 27 2023	SELL Open market or private sale	$1,225,876 $112.27 p/Share	10,919 Reduced 23.33%	35,882 Common Stock
Aug 30 2023	SELL Bona fide gift	-	190 Reduced 0.4%	46,801 Common Stock
Aug 21 2023	SELL Open market or private sale	$228,955 $107.39 p/Share	2,132 Reduced 4.34%	46,991 Common Stock
Feb 08 2023	SELL Open market or private sale	$94,816 $104.08 p/Share	911 Reduced 1.99%	44,973 Common Stock
Feb 07 2023	SELL Open market or private sale	$1,465,672 $102.33 p/Share	14,323 Reduced 24.49%	44,157 Common Stock
Feb 06 2023	SELL Open market or private sale	$110,137 $105.8 p/Share	1,041 Reduced 3.22%	31,290 Common Stock
Jan 31 2023	SELL Open market or private sale	$137,462 $109.97 p/Share	1,250 Reduced 3.95%	30,357 Common Stock
Nov 08 2022	SELL Open market or private sale	$635,453 $125.04 p/Share	5,082 Reduced 14.81%	29,234 Common Stock
Nov 08 2022	BUY Exercise of conversion of derivative security	$219,745 $43.24 p/Share	5,082 Added 12.9%	34,316 Common Stock
Nov 03 2022	SELL Open market or private sale	$564,840 $125.02 p/Share	4,518 Reduced 13.39%	29,234 Common Stock
Nov 03 2022	BUY Exercise of conversion of derivative security	$195,358 $43.24 p/Share	4,518 Added 11.81%	33,752 Common Stock
Nov 02 2022	SELL Open market or private sale	$50,000 $125.0 p/Share	400 Reduced 1.35%	29,234 Common Stock
Nov 02 2022	BUY Exercise of conversion of derivative security	$17,296 $43.24 p/Share	400 Added 1.33%	29,634 Common Stock

Darin Lippoldt

Chief Legal Officer

San Diego, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NBIX shares.

Notify only if

Value

Insider Trading

Get notified when an Neurocrine Biosciences Inc insider buys or sells NBIX shares.

Notify only if

Operation

Value

Type

News

Receive news related to NEUROCRINE BIOSCIENCES INC

Track Activities on NBIX

Account